Affinity Asset Advisors, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773195

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2023 · 73 positions · Total reported value $275.03M · Top-10 concentration 47.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 24 new · 29 cut · 20 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.1% · vs SPY -14.3% · Prev Value $2.08B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.2% · vs SPY -4.3% · Latest Value $2.15B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Affinity Asset Advisors, LLC disclosed 73 equity positions with a combined reported value of $275.03M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were APGE ($22.26M), CBAY ($16.84M), CERE ($14.95M). By sector, the heaviest allocations are Health Care 47.9%, Industrials 0.5%.

Versus the prior quarter, Affinity Asset Advisors, LLC opened 24 new positions, trimmed 29 and fully exited 20, a turnover rate of 55.3% of positions.

The largest new positions opened in Q3 2023 were APGE ($22.26M), CBAY ($16.84M), CERE ($14.95M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • APGE APOGEE THERAPEUTICS INC · $22.26M
  • CBAY CYMABAY THERAPEUTICS INC · $16.84M
  • CERE CEREVEL THERAPEUTICS HLDNG I · $14.95M
  • ACLX ARCELLX INC · $14.35M
  • CRNX CRINETICS PHARMACEUTICALS IN · $13.38M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $12.41M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $11.22M
  • XENE XENON PHARMACEUTICALS INC · $10.26M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Affinity Asset Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Affinity Asset Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 108 US equity positions with a combined value of $2.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-120744 (status: Approved), registered 2021-04-09
  • Regulatory AUM (Form ADV): $2.45B as of 2026-07-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: affinityadv.com

Portfolio Structure

  • 108 positions · $2.08B reported value (Q2 2026)
  • Top 10 holdings = 41.7% of reported value
  • Largest position: ROIV (ROIVANT SCIENCES LTD) at 6.4%
  • Average position size: $19.25M

Sector Tilt

  • Health Care 87.6%
  • Financials 1.3%
  • Materials 0.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 19 new, 34 added, 31 reduced, 12 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 47.9%
Materials 0.2%
Other 51.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.05M $22.26M 8.09%
8.09%
New
2 1.13M $16.84M 6.12%
6.12%
New
3 685.06K $14.95M 5.44%
5.44%
New
4 400.00K $14.35M 5.22%
5.22%
New
5 450.00K $13.38M 4.87%
4.87%
New
6 85.00K $12.41M 4.51%
4.51%
New
7 1.10M $11.22M 4.08%
4.08%
New
8 300.44K $10.26M 3.73%
3.73%
New
9 856.53K $7.81M 2.84%
2.84%
New
10 1.00M $7.46M 2.71%
2.71%
New
11 250.00K $6.96M 2.53%
2.53%
New
12 140.00K $6.87M 2.50%
2.50%
New
13 230.37K $6.79M 2.47%
2.47%
New
14 57.50K $6.67M 2.42%
2.42%
New
15 1.02M $6.59M 2.40%
2.40%
New
16 368.33K $6.00M 2.18%
2.18%
New
17 1.38M $5.80M 2.11%
2.11%
New
18 128.10K $4.92M 1.79%
1.79%
New
19 1.99M $4.64M 1.69%
1.69%
New
20 1.15M $4.35M 1.58%
1.58%
New
21 46.40K $4.34M 1.58%
1.58%
New
22 150.00K $4.13M 1.50%
1.50%
New
23 60.00K $4.06M 1.48%
1.48%
New
24 350.00K $3.94M 1.43%
1.43%
New
25 79.21K $3.82M 1.39%
1.39%
New
26 2.85M $3.62M 1.32%
1.32%
New
27 300.00K $3.32M 1.21%
1.21%
New
28 242.30K $2.97M 1.08%
1.08%
New
29 200.00K $2.95M 1.07%
1.07%
New
30 50.00K $2.85M 1.04%
1.04%
New
31 100.00K $2.80M 1.02%
1.02%
New
32 278.29K $2.68M 0.97%
0.97%
New
33 60.43K $2.63M 0.96%
0.96%
New
34 200.00K $2.32M 0.84%
0.84%
New
35 50.00K $2.30M 0.84%
0.84%
New
36 10.00K $2.12M 0.77%
0.77%
New
37 30.00K $2.08M 0.76%
0.76%
New
38 250.00K $1.97M 0.71%
0.71%
New
39 260.00K $1.78M 0.65%
0.65%
New
40 150.00K $1.75M 0.64%
0.64%
New
41 325.00K $1.63M 0.59%
0.59%
New
42 40.00K $1.52M 0.55%
0.55%
New
43 25.00K $1.27M 0.46%
0.46%
New
44 6.29K $1.25M 0.45%
0.45%
New
45 155.00K $1.24M 0.45%
0.45%
New
46 125.00K $1.16M 0.42%
0.42%
New
47 50.00K $1.15M 0.42%
0.42%
New
48 400.00K $1.12M 0.41%
0.41%
New
49 400.73K $1.08M 0.39%
0.39%
New
50 335.07K $1.04M 0.38%
0.38%
New

FAQ

What did Affinity Asset Advisors, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, Affinity Asset Advisors, LLC reported 73 equity positions worth $275.03M in aggregate; its largest disclosed positions were APGE ($22.26M), CBAY ($16.84M), CERE ($14.95M).

How large is Affinity Asset Advisors, LLC's portfolio?

Affinity Asset Advisors, LLC reported $275.03M of long equity holdings across 73 positions as of 2023-Q3. Top-10 holdings account for 47.6% of reported value.

What is Affinity Asset Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/affinity-asset-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →